Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
Open Vet J ; 13(1): 42-47, 2023 01.
Article in English | MEDLINE | ID: mdl-36777436

ABSTRACT

Background: Antibiotic-resistant pathogens became a real global threat to human and animal health. This needs to concentrate the efforts to minimize and control these organisms. Efflux pumps are considered one of the important strategies used by bacteria to exclude harmful materials from the cell. Inhibition of these pumps can be an active strategy against multidrug resistance pathogens. There are two sources of efflux pump inhibitors that can be used, chemical and natural inhibitors. The chemical origin efflux pump inhibitors have many toxic side effects while the natural origin is characterized by a wide margin of safety for the host cell. Aim: In this study, the ability of some plant extracts like (propolis show rosemary, clove, capsaicin, and cumin) to potentiate the inhibitory activity of some antibiotics such as (ciprofloxacin, erythromycin, gentamycin, tetracycline, and ampicillin) against Staphylococcus aureus pathogen were tested. Methods: Efflux pump inhibitory activity of the selected plant extracts was tested using an ethidium bromide (EtBr) accumulation assay. Results: The results have shown that Propolis has a significant synergistic effect in combination with ciprofloxacin, erythromycin, and gentamycin. While it has no effect with tetracycline or ampicillin. Also, no synergic effect was noticed in a combination of the minimum inhibitory concentration for the selected plant extracts (rosemary, clove, capsaicin, and cumin) with any of the tested antibiotics. Interestingly, according to the results of the EtBr accumulation assay, Propolis has potent inhibitory activity against the S. aureus (MRS usa300) pump system. Conclusion: This study suggests that Propolis might act as a resistance breaker that is able to restore the activity of ciprofloxacin, erythromycin, and gentamycin against S. aureus strains, in case of the efflux-mediated antimicrobial resistance mechanisms.


Subject(s)
Propolis , Staphylococcal Infections , Animals , Humans , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Staphylococcus aureus , Plant Extracts/pharmacology , Capsaicin/pharmacology , Capsaicin/therapeutic use , Propolis/pharmacology , Propolis/therapeutic use , Multidrug Resistance-Associated Proteins/pharmacology , Multidrug Resistance-Associated Proteins/therapeutic use , Staphylococcal Infections/microbiology , Staphylococcal Infections/veterinary , Tetracycline/pharmacology , Tetracycline/therapeutic use , Ciprofloxacin/pharmacology , Ciprofloxacin/therapeutic use , Erythromycin/pharmacology , Erythromycin/therapeutic use , Ethidium/pharmacology , Ethidium/therapeutic use , Ampicillin/pharmacology , Ampicillin/therapeutic use , Gentamicins/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL